Repatriated Funds Should Not Be Used For Liability Costs – Congressman
This article was originally published in The Tan Sheet
Executive Summary
The U.S. Treasury Department should clarify that pharmaceutical companies cannot use the tax repatriation provision of a recently enacted jobs bill to cover tort and liability expenses, House Ways & Means Health Subcommittee Ranking Member Pete Stark (D-Calif.) maintains